To investigate the mechanism of thyroid hormone action on pulmonary surfactant synthesis, we characterized the effect of triiodothyronine on phosphatidylcholine synthesis in cultured fetal rabbit lung. Since glucocorticoids stimulate surfactant synthesis and reduce the incidence of Respiratory Distress Syndrome in premature infants, we also examined the interaction of triiodothyronine and dexamethasone. The rate of choline incorporation into phosphatidylcholine was determined in organ cultures of rabbit lung maintained in serumfree Waymouth's medium. In 23-d lung cultured for 72 h, the increase in choline incorporation with triiodothyronine alone, dexamethasone alone, and triiodothyronine plus dexamethasone was 50, 62, and 161%, respectively. Both triiodothyronine and dexamethasone also increased incorporation rates with glucose, glycerol, and acetate as precursors, and stimulation with triiodothyronine plus dexamethasone was at least additive. Dexamethasone, but not triiodothyronine, affected distribution of radioactivity from [3H] acetate among phospholipids. Stimulation was first detected 8-12 h after addition of triiodothyronine, and then increased in a linear fashion. With triiodothyronine plus dexamethasone, stimulation was maximal at 48-72 h, and was supra-additive at all times. Exposure of cultured lung to dexamethasone enhanced the subsequent response to triiodothyronine, but not vice versa. When triiodothyronine was removed from cultures, there was no further stimulation and the triiodothyronine effect was partially reversed within 24 h. Half-maximal stimulation of choline incorporation occurred at a triiodothyronine concentration (0.10 nM) very similar […] no further stimulation and the triiodothyronine effect was partially reversed within 24 h. Half-maximal stimulation of choline incorporation occurred at a triiodothyronine concentration (0.10 nM) very similar to the dissociation constant for triiodothyronine binding to nuclear receptor (0.11 nM). The relative potencies of thyroid hormone analogs for nuclear binding and stimulation of phosphatidylcholine synthesis were also similar: triiodothyroacetic acid > triiodothyronine-proprionic acid > L-triiodothyronine D-triiodothyronine > thyroxine > 3,5-diethyl-3'-isopropyl-DL-thyronine 3,5-dimethyl-3'-isopropyl-L-thyronine -reverse triiodothyronine. The effect of triiodothyronine was blocked by the presence of either actinomycin D or cycloheximide, inhibitors of ribonucleic acid and protein synthesis, respectively.
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We conclude that triiodothyronine stimulates phosphatidylcholine synthesis by a process involving nuclear receptors and de novo ribonucleic acid and protein synthesis. These findings support the concept that endogenous triiodothyronine has a physiologic role in lung maturation and suggest that combined antenatal therapy with thyroid hormone and glucocorticoid may be useful for prevention of Respiratory Distress Syndrome in the premature infant.
Introduction
Adequate development of the pulmonary surfactant system is required for normal respiration at birth. Surfactant is a complex mixture of lipids and proteins characterized by a high content of saturated phosphatidylcholine (PC)', which lowers the surface tension in alveoli and thereby prevents atelectasis. A deficiency of surfactant in premature infants is the major cause of neonatal Respiratory Distress Syndrome (RDS).
Numerous studies over the past decade have established that glucocorticoids accelerate the synthesis and release of surfactant during fetal life (1) . Corticosteroid effects in the lung are mediated by receptors and involve de novo protein synthesis (2) . Administration of glucocorticoids to women in premature labor reduces the incidence of RDS in their premature infants. Treatment is not effective in every case, however. There is no benefit for infants exposed <24 h to exogenous corticosteroids, and in some studies treatment has been relatively ineffective in male infants, even after optimal duration of treatment (3) (4) (5) .
Several reports indicate that thyroid hormones also enhance lung maturation. Direct administration of thyroxine (T4) to the fetal rabbit or maternal treatment with 3,5-dimethyl-3'-isopropyl-L-thyronine (DIMIT) accelerates PC synthesis and morphologic development in the lung (6, 7) , and increases the content of PC in lavage fluid (8) . Recently, stimulation of PC synthesis by T4 and triiodothyronine (T3) has been described for fetal rat (9, 10) and rabbit (2) lung in organ culture. However, there is little information relating to the mechanism of thyroid hormone action in fetal lung.
We have previously identified nuclear receptors for T3 in lung of the fetal rabbit and human (I 1-13). This finding led us to propose that thyroid hormone effects in fetal lung were mediated through nuclear receptors. In the present study, we have characterized the effect of T3 on PC synthesis in cultured fetal rabbit lung, and compared the results with T3 binding. In addition, we describe effects of combined T3 and glucocorticoid treatment of lung cultures. The results are discussed with regard to both the mechanism of T3 action and the interaction of thyroid hormones and glucocorticoids.
Methods
Reagents. 3,5'-Diethyl-3'-isopropyl-DL-thyronine (DIET) was obtained from P. Block (Lot #PB2254A-2 11). DIMIT used in these studies was received from the late E. Jorgensen (Lot #MFM 11-10-1). L-T3, other thyroid hormone analogs, and other biochemicals were purchased from Sigma Chemical Co., St. Louis, MO. For use in the culture system, thyroid hormones were dissolved in sterile 0.1 N sodium hydroxide.
[Methy1-3H]choline (60 Ci/mmol), [6- After incubation for an additional 4 h, the tissue was washed with cold isotonic saline and frozen overnight. The tissue was sonicated, lipids were extracted, and PC was isolated by thin layer chromatography as described (2) . In some experiments, PC was extracted from the chromatography plate and reacted with osmium tetroxide; saturated and nonsaturated PC were separated according to the method described by Gross et al. (14) . The tissue content of PC was determined by assay of phosphorus (15) . In experiments using other radioactive precursors, cultures were incubated for 4 Table I ). (2) is not known. The previous experiments were carried out in Oxford, England with local rabbits, while the present study used rabbits shipped by air to San Francisco from vendors in both Montana (involving a presumably stressful overnight layover) and Washington. The data at 24d gestation were obtained early in the study with rabbits from Montana, which had a greater than expected occurrence of spontaneous abortion. In other studies, we examined the effect of removing T3 during the incubation. In the experiments shown in Table IV , cultures were exposed to a low concentration of T3 (0.2 nM) Dose response. The effect of T3 concentration was studied in dose-response experiments such as shown in Fig. 2 . Optimal response to T3 occurred at concentrations 2 Similar dose-response studies were carried out for seven other thyroid hormones. We tested the effect of D-T3, L-T4, T3-proprionic acid, triiodothyroacetic acid (TRIAC), rT3, and two synthetic noniodinated analogs (D,L-DIET, and L-DIMIT).
In initial experiments we examined stimulation of choline incorporation at a relatively high dose of each hormone (-15- fold greater than the KD for nuclear binding) (12) . Each compound stimulated choline incorporation to a similar extent in both the absence and presence of Dex (Table VI) . The results from dose-response studies are summarized in Fig. 3 Requirement for RNA and protein synthesis. The requii ment for RNA synthesis in the T3 response was investigate using actinomycin D. As shown in Fig. 4 The requirement for protein synthesis was studied usin cycloheximide. Control and hormone-treated cultures wet exposed to cycloheximide (0.4 gg/ml) during the last 24 h a 72-h incubation. As illustrated by the data shown in Tabl VII, this treatment caused only a slight reduction in cholin incorporation by control cultures, but eliminated the stimulk tion by T3. Cycloheximide was equally effective whethe present during the entire time of hormone treatment (48 h) c when added only during the last 24 h of culture (data nc shown). The response to Dex alone and to T3 plus Dex wa somewhat less sensitive to cycloheximide treatment than fo T3 (Table VII) (27) . The intracellular concentration of choline and other precursors was not determined in this study; accordingly, we cannot rule out an effect of T3, mediated by receptor, on substrate pool size.
Our data confirm and further characterize the interaction between thyroid hormones and glucocorticoids in fetal lung. There is an additive effect of T3 and Dex on choline incorporation after in vivo treatment of the fetal rat (27) , and a synergistic interaction for combined treatment in both organ (10) and monolayer (21) cultures of rat lung. A synergistic and/or permissive interaction between thyroid hormones and glucocorticoids also occurs in other biological systems (28) (29) (30) (31) . We found that the presence of both hormones gave more than additive stimulation of choline incorporation under all conditions examined. These included culturing tissue for 72 h and exposing the cultures to hormones for various times before assay, as well as determining the response during shorter periods of culture (i.e., less mature lung). Hormonal stimulation with other precursors was additive (acetate) or supra-additive (glucose and glycerol), supporting the findings with choline. The concentration of T3 producing half-maximal response was identical in the presence and absence of Dex. This would appear to rule out a glucocorticoid-induced change in lung sensitivity to T3 (receptor affinity) as the mechanism for synergy.
Although the time course of response and percent stimulation were similar for T3 and Dex, differences in the action of the two hormones were observed. T3 did not influence the distribution of radioactivity from acetate, whereas Dex increased incorporation into PC at the expense of other phospholipids. Stimulation by T3 was more sensitive to actinomycin D and cycloheximide. Prior exposure of cultures to Dex increased the rate of response to T3 whereas the reverse situation was not observed. These results support previous indications (8) (9) (10) that thyroid hormones and glucocorticoids act, at least in part, at different biochemical sites in the synthesis of PC. This conclusion is consistent with supra-additive stimulation. One possibility might be the induction of phosphatidic acid phosphatase by corticosteroids and induction of enzyme(s) involved in fatty acid synthesis by T3. These considerations also suggest that the two hormones do not act entirely through a common mediator, such as cAMP (21), to enhance PC biosynthesis.
Glucocorticoids, but not thyroid hormones, increase f3-adrenergic receptors in fetal lung (32, 33) , indicating that the two hormones also differ in their effect on a protein not directly involved in surfactant synthesis.
Endogenous thyroid hormones appear to influence the normal process of lung maturation. In fetal sheep, thyroidectomy lowered lecithin/sphingomyelin values in tracheal fluid and delayed morphologic development (34). In rabbit lung, the number of nuclear receptor sites occupied by endogenous thyroid hormone increases about threefold between days 23 and 28 of gestation (12). Our observation that physiologic concentrations of T3 stimulate PC synthesis supports the possible role of endogenous T3 and T4.
These data, along with previous information (2, 6-10, 22, 35) and preliminary data with human fetal lung in culture (36) , support the possibility that thyroid hormone treatment may benefit premature infants at risk for RDS. Although prenatal glucocorticoid therapy reduces the incidence of RDS, this treatment is not always effective. Potentially, combined antenatal therapy with thyroid hormone and glucocorticoid could be more efficacious than corticosteroid alone.
